Cannabis Bioscience International Holdings (CBIH) Common Equity (2022 - 2025)
Historic Common Equity for Cannabis Bioscience International Holdings (CBIH) over the last 4 years, with Q3 2025 value amounting to -$1.2 million.
- Cannabis Bioscience International Holdings' Common Equity fell 1809.04% to -$1.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$1.2 million, marking a year-over-year decrease of 1809.04%. This contributed to the annual value of -$1.2 million for FY2025, which is 783.77% down from last year.
- According to the latest figures from Q3 2025, Cannabis Bioscience International Holdings' Common Equity is -$1.2 million, which was down 1809.04% from -$1.2 million recorded in Q2 2025.
- In the past 5 years, Cannabis Bioscience International Holdings' Common Equity registered a high of -$405301.0 during Q4 2022, and its lowest value of -$1.2 million during Q3 2025.
- Moreover, its 4-year median value for Common Equity was -$1.0 million (2024), whereas its average is -$912384.3.
- As far as peak fluctuations go, Cannabis Bioscience International Holdings' Common Equity plummeted by 10771.77% in 2023, and later crashed by 783.77% in 2025.
- Cannabis Bioscience International Holdings' Common Equity (Quarter) stood at -$405301.0 in 2022, then plummeted by 107.72% to -$841882.0 in 2023, then plummeted by 38.36% to -$1.2 million in 2024, then decreased by 6.99% to -$1.2 million in 2025.
- Its Common Equity was -$1.2 million in Q3 2025, compared to -$1.2 million in Q2 2025 and -$1.2 million in Q1 2025.